Global Innovative Platforms (GIPL) Total Current Liabilities (2020 - 2026)
Global Innovative Platforms' (GIPL) quarterly Total Current Liabilities came in at $7791.0 in Q2 2026, down 72.0% year-over-year from $27823.0 in Q2 2025, and up 241.11% quarter-over-quarter from $2284.0 in Q1 2026.
Analysis
Global Innovative Platforms (GIPL) Total Current Liabilities (2020 - 2026) Analysis & Trends
Global Innovative Platforms has disclosed Total Current Liabilities across 7 years of filings, most recently posting $7791.0 for Q2 2026.
- In Q2 2026, Total Current Liabilities fell 72.0% year-over-year to $7791.0; the TTM figure through Jun 2026 stood at $7791.0 (down 72.0% YoY), while the FY2025 annual figure was $11609.0, down 64.98% from the prior year.
- Total Current Liabilities came in at $7791.0 for Q2 2026 at Global Innovative Platforms, up from $2284.0 in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $364368.0 in Q3 2023 to a low of $2284.0 in Q1 2026.
- Average Total Current Liabilities over 5 years is $115716.8, with a median of $56578.0 recorded in 2022.
- Year-over-year, Total Current Liabilities jumped 556.62% in 2022 and sank 98.39% in 2025.
- Over 5 years, Total Current Liabilities stood at $234283.0 in 2022, then slipped by 15.4% to $198200.0 in 2023, then slumped by 92.73% to $14407.0 in 2024, then surged by 356.61% to $65784.0 in 2025, then plunged by 88.16% to $7791.0 in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $7791.0 in Q2 2026, $2284.0 in Q1 2026, and $65784.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.31 Bn | 40.11 Bn | 779.09 Mn | 1.29 Bn |
| 2 | Zoetis | 30.55 Bn | 28.87 Bn | 1.05 Bn | 2.06 Bn |
| 3 | Elanco Animal Health | 11.57 Bn | 11.04 Bn | 798.00 Mn | 1.85 Bn |
| 4 | Phibro Animal Health | 1.49 Bn | 1.40 Bn | 134.40 Mn | 316.47 Mn |
| 5 | Immucell | 89.38 Mn | 80.52 Mn | 2.44 Mn | 4.44 Mn |
| 6 | Zhengye Biotechnology Holding | 76.69 Mn | 69.60 Mn | - | 16.99 Mn |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 7,791.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7,791.00 |
| Mar 31, 2026 | 2,284.00 |
| Dec 31, 2025 | 65,784.00 |
| Sep 30, 2025 | 11,609.00 |
| Jun 30, 2025 | 27,823.00 |
| Mar 31, 2025 | 3,229.00 |
| Dec 31, 2024 | 14,407.00 |
| Sep 30, 2024 | 33,153.00 |
| Jun 30, 2024 | 216,897.00 |
| Mar 31, 2024 | 200,997.00 |
| Dec 31, 2023 | 198,200.00 |
| Sep 30, 2023 | 364,368.00 |
| Jun 30, 2023 | 241,761.00 |
| Mar 31, 2023 | 241,711.00 |
| Dec 31, 2022 | 234,283.00 |
| Sep 30, 2022 | 130,471.00 |
| Jun 30, 2022 | 47,372.00 |
| Mar 31, 2022 | 40,763.00 |
| Dec 31, 2021 | 35,680.00 |
| Sep 30, 2021 | 29,160.00 |